HomeVXL • CVE
add
Vaxil Bio Ltd
Previous close
$0.25
Year range
$0.20 - $0.33
Market cap
671.20K CAD
Avg Volume
3.43K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 74.00K | 27.59% |
Net income | -70.00K | -20.69% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 403.00K | -56.20% |
Total assets | 684.00K | -26.69% |
Total liabilities | 40.00K | -59.18% |
Total equity | 644.00K | — |
Shares outstanding | 2.74M | — |
Price to book | 1.02 | — |
Return on assets | -26.11% | — |
Return on capital | -27.21% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -70.00K | -20.69% |
Cash from operations | -47.00K | -135.00% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -45.00K | -150.00% |
Free cash flow | -19.25K | -505.26% |
About
Founded
2006
Headquarters
Website
